- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 19/00 - Peptides hybrides
Détention brevets de la classe C07K 19/00
Brevets de cette classe: 11372
Historique des publications depuis 10 ans
|
401
|
522
|
545
|
554
|
627
|
681
|
701
|
834
|
740
|
79
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20355 |
194 |
| The Trustees of the University of Pennsylvania | 4382 |
113 |
| The Board of Trustees of the Leland Stanford Junior University | 6594 |
75 |
| Regeneron Pharmaceuticals, Inc. | 4505 |
70 |
| National Research Council of Canada | 1579 |
62 |
| The General Hospital Corporation | 4793 |
57 |
| Acceleron Pharma Inc. | 349 |
57 |
| Osaka University | 3360 |
56 |
| Chugai Seiyaku Kabushiki Kaisha | 1387 |
55 |
| The University of Tokyo | 4285 |
54 |
| JCR Pharmaceuticals Co., Ltd. | 225 |
52 |
| Board of Regents, The University of Texas System | 5989 |
50 |
| President and Fellows of Harvard College | 6049 |
49 |
| F. Hoffmann-La Roche AG | 7893 |
48 |
| Memorial Sloan-Kettering Cancer Center | 1985 |
45 |
| The Johns Hopkins University | 5772 |
43 |
| Nanjing Legend Biotech Co., Ltd. | 171 |
42 |
| Amgen Inc. | 4290 |
40 |
| Novartis AG | 10494 |
38 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2942 |
37 |
| Autres propriétaires | 10135 |